{
    "Trade/Device Name(s)": [
        "BD MAX MRSA XT"
    ],
    "Submitter Information": "GeneOhm Sciences Canada Inc. (BD Diagnostics)",
    "510(k) Number": "K133605",
    "Predicate Device Reference 510(k) Number(s)": [
        "K120138"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQX",
        "00I"
    ],
    "Summary Letter Date": "November 22, 2013",
    "Summary Letter Received Date": "November 25, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Methicillin-resistant Staphylococcus aureus (MRSA) DNA",
        "SCCmec cassette at orfX junction",
        "mecA gene",
        "mecC gene"
    ],
    "Specimen Type(s)": [
        "Nasal swab"
    ],
    "Specimen Container(s)": [
        "BD MAX MRSA XT Sample Buffer Tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BD MAX System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Nucleic acid amplification",
        "Hydrolysis probe detection (TaqMan)",
        "Automated sample preparation"
    ],
    "Methodologies": [
        "PCR",
        "Fluorogenic hybridization probe detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Automated system",
        "Cartridge",
        "Reagent",
        "Software",
        "Accessory",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for BD MAX MRSA XT automated real-time PCR assay for qualitative detection of MRSA DNA from nasal swabs using the BD MAX System",
    "Indications for Use Summary": "Automated qualitative in vitro diagnostic test for direct detection of MRSA DNA from nasal swabs in patients at risk for nasal colonization; aids prevention and control of MRSA infections in healthcare settings, not for diagnosis or treatment monitoring",
    "fda_folder": "Microbiology"
}